Literature DB >> 25813972

Health security preparedness and industry trends.

Stanley T Crooke.   

Abstract

Given the number and diversity of risks in today's complex society, it is essential to focus on global risks that can be reduced through affordable, feasible approaches. Thus, the risks that should command the greatest focus are emergent infectious diseases. Fortunately, preparing responses to such threats can be entirely agnostic as to source or intent of the threat. This article considers the emergent infectious clinical threats, characterizes the steps that are essential to take to prepare for such threats, and discusses the roles that the biomedical industry should play in both the preparation for and response to such threats. The author assesses the readiness of the industry to play its role and suggests steps to consider to enable a more robust response.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25813972      PMCID: PMC4394158          DOI: 10.1089/hs.2015.0002

Source DB:  PubMed          Journal:  Health Secur        ISSN: 2326-5094


  4 in total

Review 1.  Diagnosing the decline in pharmaceutical R&D efficiency.

Authors:  Jack W Scannell; Alex Blanckley; Helen Boldon; Brian Warrington
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  The history of vaccines and immunization: familiar patterns, new challenges.

Authors:  Alexandra Minna Stern; Howard Markel
Journal:  Health Aff (Millwood)       Date:  2005 May-Jun       Impact factor: 6.301

Review 3.  Evolution and emergence of therapeutic monoclonal antibodies: what cardiologists need to know.

Authors:  Ian N Foltz; Margaret Karow; Scott M Wasserman
Journal:  Circulation       Date:  2013-06-04       Impact factor: 29.690

Review 4.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.